Saul A Rosenberg

Clinical Focus

• Cancer > Lymphoma
• Hodgkin's Disease
• Hodgkin's Disease - Hematology
• Hodgkin's Disease - Medical Oncology
• Lymphoma

Professional Education

Research Interests

Clinical Investigations of Hodgkin’s Disease: Current trials are defining (1) the utility of an abbreviated chemotherapy and minimal radiotherapy for favorable, clinically-staged patients with the disease; (2) the development of new dose-intensive chemotherapy programs for unfavorable and advanced disease. In collaboration with radiotherapists and Dr. Sandra Horning, careful retrospective and prospective studies of fertility, cardiopulmonary and secondary neoplasms are being done.

Clinico-laboratory Studies in the Non-Hodgkin’s Lymphomas: A major research interest of Dr. Rosenberg is the clinical, pathological and molecular basis of diagnosis, evolution, treatment and understanding of the non-Hodgkin’s lymphomas. This research is performed by a large interdisciplinary group of investigators which Dr. Ronald Levy directs.

Publications

• Lymphography: a great advance, abandoned. Rosenberg SA, J Clin Oncol. 2008; 26 (35): 5662-3
• Follicular lymphoma revisited. Rosenberg SA, J Clin Oncol. 2008; 26 (4): 515-6
• Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease. Advani R, Maeda L, Lavori P, Quon A, Hoppe R, Breslin S, Rosenberg SA, Horning SJ. J Clin Oncol. 2007; 25 (25): 3902-7
• Splenic diffuse large B-cell lymphoma in a patient with type 1 Gaucher disease: Diagnostic and therapeutic challenges. Brody JD, Advani R, Shin LK, Bingham DB, Rosenberg SA. Ann Hematol. 2006; 85 (11): 817-20
• Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy. Advani R, Rosenberg SA, Horning SJ. J Clin Oncol. 2004; 22 (8): 1454-9